Gapping down
In reaction to earnings/guidance:
- CRUS -7%, RMBS -6.2%, PBI -5.7%, BP -4.7%, HOG -3.6%, RACE -3.4%, WWD -2.8% (also increases dividend), VRTX -2.1%, AQUA -2%, NXPI -1.7%, LITE -1.7%, ARCB -1.5%
Other news:
- IMVT -59% (announces a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401)
- SNDL -14% (prices registered offering of 60.5 mln Series A Units and 14.0 mln Series B Units)
- FMS -10.7% (expects significant negative impact on 2021 net income from accelerated COVID-19 related excess mortality of dialysis patients)
- BBBY -5.4% (DE Shaw discloses 5% stake; also completes initial $225 mln share buyback program; will extend current program given recent volatility)
- MITK -5.2% (convertible notes offering)
- ARQT -3.8% (stock offering, and mixed shelf offering)
- IVR -3.2% (announces upsizing and pricing of its public offering of 24 million shares of its common stock at $3.83/share )
- NBEV -3% (stock offering)
- LI -2.3% (reports January deliveries)
- RVMD -2.2% (stock offering)
- AXTA -2.2% (delays Q4 earnings release due to operational matter; guides Q4 revs above consensus)
Analyst comments:
- LLNW -2.4% (downgraded to Market Perform from Outperform at Cowen)